(Q33543492)

27 July 2017

1 reference

title

Steroid-induced osteoporosis. Are your asthmatic patients at risk? (English)

1 reference

27 July 2017

0 references

0 references

C B Niewoehner

1

1 reference

27 July 2017

D E Niewoehner

series ordinal

2

1 reference

27 July 2017

language of work or name

English

0 references

publication date

1 March 1999

1 reference

27 July 2017

published in

Postgraduate Medicine

1 reference

27 July 2017

volume

105

1 reference

27 July 2017

issue

3

1 reference

27 July 2017

page(s)

79-83, 87-8, 91

1 reference

Glucocorticoid osteoporosis--mechanisms and management

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.3810%2FPGM.1999.03.598

Reduction of serum testosterone levels during chronic glucocorticoid therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.1999.03.598

Beclomethasone inhalation decreases serum osteocalcin concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.1999.03.598

Not all postmenopausal women on chronic steroid and estrogen treatment are osteoporotic: predictors of bone mineral density

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.1999.03.598

Calcium and vitamin D3 supplementation prevents bone loss in the spine secondary to low-dose corticosteroids in patients with rheumatoid arthritis. A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.1999.03.598

Cyclical etidronate plus ergocalciferol prevents glucocorticoid-induced bone loss in postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.1999.03.598

Prevention of further bone mass loss by nasal calcitonin in patients on long term glucocorticoid therapy for asthma: a two year follow up study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.1999.03.598

Is addition of sodium fluoride to cyclical etidronate beneficial in the treatment of corticosteroid induced osteoporosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.1999.03.598

21 January 2018

Identifiers

DOI

10.3810/PGM.1999.03.598

1 reference

27 July 2017

1 reference